Smith & Nephew Regulatory News (SN.)

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Smith & Nephew plc ordinary shares of USD 0.20 each

Identification code

ISIN: GB0009223206

Nature of the transaction

Sale of ordinary shares. Following the sale, each individual continues to maintain a shareholding in accordance with the shareholding guidelines.

Date of Transaction

Phil Cowdy: 2023 - 04 - 27 & Bradley Cannon: 2023 - 05 - 02

Place of Transaction

London Stock Exchange (XLON)

Name (Position)

Director / PDMR

Price (£)

Volume

Aggregated information

Total Ordinary Share Holding following the transaction *

Total Ordinary Share Holding as a % of the Company's ISC following the transaction *

Phil Cowdy

(Chief Corporate Development and Corporate Affairs Officer)

PDMR

12.83280

12,083

N/A Single Transaction

49,000.99309 ordinary shares

0.00558%

Bradley Cannon

(President, Global Orthopaedics)

PDMR

12.926813

9,500

N/A Single Transaction

117,819.37494 ordinary shares

(including 3,599.09977 in ADS')

0.01342%